AlphaCentric Advisors »

Ascendis Pharma A S shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $691k 3.2k 213.24

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
Franklin Resources
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
American Century Companies
Perceptive Advisors
Principal Financial Group
Susquehanna International

View all funds holding Ascendis Pharma A S